The Q226H Mutation in Avian H5N1 Hemagglutinin Mediates a Path towards Structural Adaptation in Humans
Ross A. EdwardsiD, Oluwafemi F. AduiD, Egor P. TchesnokoviD, Dana KocíncováiD, Emma WoolneriD, Zoe TurneriD, Duong T. BuiiD, Lara K. MahaliD, Nathan J. ZelyasiD, John S. KlasseniD, Andrei P. DrabovichiD, Kalyan DasiD, Matthias GötteiD
Abstract
The global outbreak of highly pathogenic avian influenza (HPAI) A(H5N1) among birds and the spillover to mammals increases the risk for humans. A recent case in British Columbia with a clade 2.3.4.4b H5 virus infection revealed a mixture of 226Q/H in the receptor-binding site of hemagglutinin. While significant changes in pre-existing immunity by H1 or H3 polyclonal sera are not evident, we show that the Q226H mutation enables binding to human-type a2-6 sialic acid receptors. High-resolution cryo-EM structures provide a basis for the alteration in receptor preference and show that a possible path towards human adaptation also requires a conformational change of the bound a2-6-sialylated glycan. Continued surveillance for additional mutations that could enhance this phenotype is warranted.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors
María Ríos Carrasco, Ting-Hui Lin, … Robert P. de Vries·Proceedings of the National Academy of SciencesPeer-reviewed·Apr 15, 2025
- Acquisition of specific human respiratory tract binding of 2.3.4.4b H5N1 hemagglutinins requires multiple mutations
María Ríos Carrasco, Mafalda F Guerreiro Cabana, … Robert P. de Vries·Journal of VirologyPeer-reviewed·Aug 10, 2026
- H5N1 2.3.4.4b HA E190D and Q226H mutations, picked up as minority variants in a patient, result in an inability to bind sialic acid.
Eszter Kovacs, María Ríos Carrasco, … Robert P. de Vries·VirologyPeer-reviewed·May 12, 2026
- Mutations in severe human H5N1 cases facilitate evasion from human mucus and antivirals
Ksenia Sukhova, Jiayun Yang, … Hannah Klim·bioRxiv·Jul 28, 2026
- H5N1 influenza binding and cell entry via human class II MHC, and blocking by cross-reactive antibodies
Taylor A. Pursell, Artem I. Mikelov, … Scott Dexter Boyd·bioRxiv·Jul 26, 2026
- Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain
T. A. Garretson, J. G. Petrie, … S. E. Hensley·bioRxiv·Jan 17, 2018